Hillsdale Investment Management Inc. Ultragenyx Pharmaceutical Inc. Transaction History

Hillsdale Investment Management Inc.

  • $1.21 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Jul 29, 2021
SELL
$92.19 - $115.71 $709,863 - $890,967
-7,700 Closed
0 $0
Q4 2020

Feb 09, 2021
SELL
$84.4 - $177.39 $295,400 - $620,865
-3,500 Reduced 31.25%
7,700 $1.07 Million
Q3 2020

Nov 13, 2020
BUY
$72.98 - $90.0 $817,376 - $1.01 Million
11,200 New
11,200 $921,000

Others Institutions Holding RARE

# of Institutions
326
Shares Held
85.7M
Call Options Held
520K
Put Options Held
406K
View Full List

About Ultragenyx Pharmaceutical Inc.

RARE Quotes by TradingView
  • Ticker RARE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,036,896
  • Market Cap $3.42B
  • Description
  • Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...
More about RARE
Track This Portfolio

Track Hillsdale Investment Management Inc. Portfolio

Follow Hillsdale Investment Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hillsdale Investment Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hillsdale Investment Management Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email